NRP2

Chr 2

neuropilin 2

Also known as: NP2, NPN2, PRO2714, VEGF165R2

The protein functions as a transmembrane receptor that binds semaphorins and VEGF, regulating neuronal proliferation, survival, differentiation, and axon guidance through MAPK signaling pathways. Mutations cause autosomal dominant developmental disorders affecting the nervous system and potentially cardiovascular development. This gene is highly constrained against loss-of-function variants, indicating that such mutations are likely to have significant clinical consequences.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 0.47
Clinical SummaryNRP2
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.31) despite low pLI — interpret in context.
📋
ClinVar Variants
12 unique Pathogenic / Likely Pathogenic· 199 VUS of 400 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.47LOEUF
pLI 0.001
Z-score 4.47
OE 0.31 (0.200.47)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
1.18Z-score
OE missense 0.86 (0.800.93)
472 obs / 549.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.31 (0.200.47)
00.351.4
Missense OE0.86 (0.800.93)
00.61.4
Synonymous OE1.04
01.21.6
LoF obs/exp: 15 / 48.6Missense obs/exp: 472 / 549.9Syn Z: -0.51
DN
0.6746th %ile
GOF
0.6639th %ile
LOF
0.3162th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

400 submitted variants in ClinVar

Classification Summary

Pathogenic12
VUS199
Likely Benign149
Benign12
Conflicting1
12
Pathogenic
199
VUS
149
Likely Benign
12
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
12
0
12
Likely Pathogenic
0
0
0
0
0
VUS
5
190
4
0
199
Likely Benign
0
20
32
97
149
Benign
1
2
1
8
12
Conflicting
1
Total621249105373

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

NRP2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →